Malaria Chemoprophylaxis in the Age of Drug Resistance. II. Drugs That May Be Available in the Future
Open Access
- 1 August 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (3) , 381-385
- https://doi.org/10.1086/321866
Abstract
All current regimens of malaria chemoprophylaxis have serious drawbacks as a result of either suboptimal efficacy, difficulty with medication compliaKeywords
This publication has 14 references indexed in Scilit:
- Malaria Chemoprophylaxis in the Age of Drug Resistance. I. Currently Recommended Drug RegimensClinical Infectious Diseases, 2001
- Seroprevalence of hepatitis C virus in the general population of northwest Tanzania.The American Journal of Tropical Medicine and Hygiene, 2000
- Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in ThailandThe Journal of Infectious Diseases, 1999
- Double‐Blind, Randomized, Placebo‐Controlled Assessment of Chloroquine/Primaquine Prophylaxis for Malaria in Nonimmune Colombian SoldiersClinical Infectious Diseases, 1999
- Lesson of the week: Malaria at Christmas: risks of prophylaxis versus risks of malariaBMJ, 1998
- Primaquine Prophylaxis against Malaria in Nonimmune Colombian Soldiers: Efficacy and Toxicity: A Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 1998
- First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.The American Journal of Tropical Medicine and Hygiene, 1998
- Malaria among United States troops in SomaliaThe American Journal of Medicine, 1996
- Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malariaThe Lancet, 1995
- The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605Pathogens and Global Health, 1993